No deal Brexit could have detrimental impact for four million people in UK living with a rare disease

By Neuroendocrine Cancer UK

Posted 6 years ago

16/12/2020 11am

No deal Brexit could have detrimental impact for four million people in UK living with a rare disease

Experts have warned that a ‘no deal’ Brexit will result in the exclusion of the UK from the 24 European Reference Networks (ERNs) that were established to improve the care of patients bearing the lifelong burden of a rare disease, which require highly specialised diagnosis and treatment.

Read Full Press Release here

Catch up on the latest news, stories and updates

Ongoing variability in the supply of pancreatic enzyme replacement therapy (PERT) — particularly Creon® 25,000iu capsules — has left some people struggling to obtain their prescription. ...